Live Cell Imaging Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-1799 | Report Format : | Status : Upcoming |

Abstract

Global Live Cell Imaging Market: Overview

Live cell imaging market makes use of the time-lapse microscopy to analyze and study the living cells. Scientists use time-lapse microscopy for better understanding by using cellular dynamics. The live cell imaging technique is getting much popular in the healthcare industry. In addition, pharmaceutical companies are focusing on developing personalized medicines with the help of live cell imaging technique.

Global Live Cell Imaging Market: Growth Factors

Increasing concerns about cancer are one of the major factors that are responsible for the growth of the live cell imaging market. The government is actively participating in financing cell-based research. Live cell imaging has a wide area of application and it is used in understanding the cellular structures and the dynamic processes. It is extensively used for studying the enzyme activity, cellular integrity, exocytosis & endocytosis, localization of molecules, and protein trafficking. Live cell imaging is broadly applied to monitor the molecules in live animals. In order to develop new medicines pharmaceutical companies are heavily using live cell imaging techniques in the research and development activities. It is also used in the high content screening; this is expected to foster the market growth. The cost required for the live cell imaging is very high and lack of the skilled professionals are factors that may hinder the live cell imaging market growth.

Global Live Cell Imaging Market: Segmentation

The live cell imaging market is classified based on technology, application, and product. The technology segment is fragmented into the high content screening, fluorescence recovery after photobleaching, multiphoton excitation microscopy, ratiometric imaging, fluorescence resonance energy transfer, total internal reflection fluorescence microscopy, and fluorescence in situ hybridization. The application segment is divided into developmental biology, cell biology, stem cell & drug discovery, and others. On the basis of product, the market is segregated into software, instruments, and consumables. The instruments segment is further sub-segmented into microscopes & image capturing devices, standalone systems, and cell analyzers.

Global Live Cell Imaging Market: Regional Analysis

Geographically, the live cell imaging market is segmented into North America, Europe, Latin America, Asia-Pacific, and the Middle East & Africa. North America and Europe are major contributors to the market as they are early adopters of technology. The government in these regions are supporting by largely investing in the research and development using live cell imaging, thus anticipating to fuel the market growth. The U.S. accounted for the largest market share for live cell imaging in North America. Asia-Pacific region is witnessing robust growth in the market owing to the presence of developing nations such as China and India this will give rise to the live cell imaging market growth.

Global Live Cell Imaging Market: Competitive Players

Major prominent market players in the global live cell imaging market include Thermo Fisher Scientific, Inc., Carl Zeiss AG, Sigma-Aldrich Corporation, Danaher Corporation, Olympus Corporation, Nikon Corporation, and GE Healthcare. Other influencing players include Dickinson and Company, Molecular Devices, Perkinelmer, Inc., LLC., and Becton.

Global Live Cell Imaging Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Report Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Vitreous Tamponades Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2539 | Report Format:

Global Vitreous Tamponades Market: Overview Vitreous tamponades are the postoperative devices utilized in the retinal detachment vitrectomy processes. Retinal detachment is extremely grave medical condition and if not taken care of on time, can result in eternal vision loss. Vitrectomy is a surg...Read More

Operating Room Equipment Market by Product (Anesthesia Devices, Endoscopes, Operating room Lights, Operating Tables, Electrosurgical Devices, Surgical Imaging Devices and Patient Monitors), For Hospitals, Outpatient Facilities and Ambulatory Surgical Centers: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016-2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2515 | Report Format:

The operating room equipment market report includes comprehensive and profound analysis on the global and regional level. The report gives historic data of 2014 along with a forecast from 2017 to 2022 based on revenue (USD Billion). The study comprises drivers, restraints, and opportunities for th...Read More

Heart Valve Devices Market by Procedure (Heart Valve Replacement Devices (Mechanical Valve, Bioprosthetic Valve, TAVR) & Position (Mitral Valve, Aortic Valve, Other), Heart valve Repair Devices (Surgical Valve, Balloon Valvuloplasty Devices, TMVR)), by End User (Hospitals and Ambulatory Surgical Centers), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016- 2022

Dec-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2511 | Report Format:

The report covers forecast and analysis for the Heart Valve Devices Market on a global and regional level. The study provides historical data from 2014 along with a forecast from 2017 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the heart valve devices market ...Read More

Choose License Type:
Latest Published Reports

View All Published Reports